Generic drugmakers in India launch affordable Semaglutide versions, targeting a $1 billion diabetes and weight loss market.

A drug that cost over Rs 10,000 a month is now available for as little as Rs 220 a shot. Multiple companies have entered the ...

Right then, let’s talk about enterprise integration platforms. It’s 2026, and things have moved on a bit, haven’t they? If ...

Cryptocurrency exchange Zoomex has outlined its liquidity and execution infrastructure strategy as automated trading systems continue to play a growing role in ...